385 related articles for article (PubMed ID: 6328660)
41. Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS.
Vilmer E; Barre-Sinoussi F; Rouzioux C; Gazengel C; Brun FV; Dauguet C; Fischer A; Manigne P; Chermann JC; Griscelli C
Lancet; 1984 Apr; 1(8380):753-7. PubMed ID: 6143082
[TBL] [Abstract][Full Text] [Related]
42. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
43. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
[TBL] [Abstract][Full Text] [Related]
44. Isolation of a new human retrovirus from West African patients with AIDS.
Clavel F; Guétard D; Brun-Vézinet F; Chamaret S; Rey MA; Santos-Ferreira MO; Laurent AG; Dauguet C; Katlama C; Rouzioux C
Science; 1986 Jul; 233(4761):343-6. PubMed ID: 2425430
[TBL] [Abstract][Full Text] [Related]
45. [LAV type II: a second retrovirus associated with AIDS in West Africa].
Clavel F; Brun-Vézinet F; Guétard D; Chamaret S; Laurent A; Rouzioux C; Rey M; Katlama C; Rey F; Champelinaud JL
C R Acad Sci III; 1986; 302(13):485-8. PubMed ID: 3013382
[TBL] [Abstract][Full Text] [Related]
46. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
47. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
48. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
49. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
[TBL] [Abstract][Full Text] [Related]
50. HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy.
Epstein LG; Sharer LR; Cho ES; Myenhofer M; Navia B; Price RW
AIDS Res; 1984-1985; 1(6):447-54. PubMed ID: 6100783
[TBL] [Abstract][Full Text] [Related]
51. Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
Tschachler E; Groh V; Popovic M; Mann DL; Konrad K; Safai B; Eron L; diMarzo Veronese F; Wolff K; Stingl G
J Invest Dermatol; 1987 Feb; 88(2):233-7. PubMed ID: 3100656
[TBL] [Abstract][Full Text] [Related]
52. Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome.
Dorsett B; Cronin W; Chuma V; Ioachim HL
Am J Med; 1985 Apr; 78(4):621-6. PubMed ID: 2984932
[TBL] [Abstract][Full Text] [Related]
53. AIDS: what is now known. I. History and immunovirology.
Selwyn PA
Hosp Pract (Off Ed); 1986 May; 21(5):67-76, 81-2. PubMed ID: 3009507
[No Abstract] [Full Text] [Related]
54. Immunopathology associated with human lymphotropic retroviruses.
Ruscetti FW
Surv Synth Pathol Res; 1985; 4(3):216-26. PubMed ID: 2421386
[TBL] [Abstract][Full Text] [Related]
55. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.
Nicholson JK; McDougal JS; Spira TJ; Cross GD; Jones BM; Reinherz EL
J Clin Invest; 1984 Jan; 73(1):191-201. PubMed ID: 6228564
[TBL] [Abstract][Full Text] [Related]
56. Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain.
Sharer LR; Epstein LG; Cho ES; Joshi VV; Meyenhofer MF; Rankin LF; Petito CK
Hum Pathol; 1986 Mar; 17(3):271-84. PubMed ID: 3005158
[TBL] [Abstract][Full Text] [Related]
57. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
58. Human T-cell leukemia viruses (HTLV): a unique family of pathogenic retroviruses.
Broder S; Gallo RC
Annu Rev Immunol; 1985; 3():321-36. PubMed ID: 2998418
[No Abstract] [Full Text] [Related]
59. The time from infection with human immunodeficiency virus (HIV) to the onset of AIDS.
Taylor JM; Schwartz K; Detels R
J Infect Dis; 1986 Oct; 154(4):694-7. PubMed ID: 3018095
[No Abstract] [Full Text] [Related]
60. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
